ADRENERGIC ANTAGONISTS
Adrenergic antagonists prevent the
response of adrenergic nerve stimulation. These drugs block either alpha (α) or
beta (β) adrenergic receptors. Adrenergic blocking agents of the a-type are
ergot alkaloids (e.g. ergonovine, ergotamine, ydroergotamine), yohimbine
alkaloids (e.g. yohimbine), and benzodioxanes. The adrenergic blockers
apparently possess suitable affinity for adrenergic o-receptors but lack of the
intrinsic activity characteristic of the natural neuroeffector.
β-Adrenergic blocking drugs are
structurally related to isopropylarterenol. They block the actions of
catecholamines mediated through β-receptor stimulation. Thus, the f-receptor
stimulating action of adrenaline and isoproterenol are blocked but positive
chronotropic effects of calcium, barium, theophylline and digitalis are not
affected. Sotalol, timolol, dichloroisoproterenol (DCI), oxprenolol, pindolol,
propranol, acebutolol, atenolol, metoprolol and labetalol are the β -adrenergic
blocking agents.
Comments
Post a Comment